PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-4.55%
Negative net income growth while CRWD stands at 30.05%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
8.03%
D&A growth well above CRWD's 6.21%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
20.74%
Lower deferred tax growth vs. CRWD's 61.99%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
-5.87%
Negative yoy SBC while CRWD is 13.23%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
167.10%
Slight usage while CRWD is negative at -200.00%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-141.33%
Both yoy AR lines negative, with CRWD at -124.34%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
144.41%
Growth well above CRWD's 100.00%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
86.17%
Well above CRWD's 14.15%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
71.57%
Some CFO growth while CRWD is negative at -13.35%. John Neff would note a short-term liquidity lead over the competitor.
-8.23%
Negative yoy CapEx while CRWD is 64.44%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-19.36%
Negative yoy acquisition while CRWD stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-55.35%
Negative yoy purchasing while CRWD stands at 31.64%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-20.55%
Both yoy lines are negative, with CRWD at -36.63%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
61.05%
We have some outflow growth while CRWD is negative at -9.26%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-520.00%
We reduce yoy invests while CRWD stands at 52.10%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
98.94%
Debt repayment growth of 98.94% while CRWD is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-37.72%
Both yoy lines negative, with CRWD at -200.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
56.57%
Buyback growth of 56.57% while CRWD is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.